FDA Drug Recalls
10 recalls · Class II, newest first
Class II · Moderate risk Completed Aug 19, 2025
Reason Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and…
Class II · Moderate risk Completed Jul 9, 2025
Reason Sub-Potent Drug: Subpotent assay results during stability testing.
Class II · Moderate risk Completed May 27, 2025
Reason CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Class II · Moderate risk Completed May 27, 2025
Reason CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Class II · Moderate risk Completed Mar 21, 2025
Reason Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Class II · Moderate risk Completed Mar 7, 2025
Reason CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Class II · Moderate risk Completed Mar 7, 2025
Reason CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Class II · Moderate risk Completed Feb 18, 2025
Reason Lack of Assurance of Sterility: due to a quality control process deviation
Class II · Moderate risk Completed Feb 6, 2025
Reason Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Class II · Moderate risk Completed Jan 31, 2025
Reason Lack of Assurance of Sterility